These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4933321)

  • 1. Drug sensitivity and mutability to drug resistance associated with the presence of an R factor.
    Yoshikawa M
    Genet Res; 1971 Feb; 17(1):1-7. PubMed ID: 4933321
    [No Abstract]   [Full Text] [Related]  

  • 2. The problems of drug-resistant pathogenic bacteria. Elimination of bacterial episomes by DNA-complexing compounds.
    Hahn FE; Ciak J
    Ann N Y Acad Sci; 1971 Jun; 182():295-304. PubMed ID: 4936665
    [No Abstract]   [Full Text] [Related]  

  • 3. Naturally occurring R factor, derepressed for pilus synthesis, belonging to the same compatibility group as the sex factor F of Escherichia coli K-12.
    Dennison S
    J Bacteriol; 1972 Jan; 109(1):416-22. PubMed ID: 4109889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of the lethality of induced lambda prophage by an isogenic lambda plasmid.
    Friedman DI; Yarmolinsky MB
    Virology; 1972 Nov; 50(2):472-81. PubMed ID: 4564526
    [No Abstract]   [Full Text] [Related]  

  • 5. Nalidixic acid-resistant auxotrophs of Escherichia coli.
    Helling RB; Adams BS
    J Bacteriol; 1970 Nov; 104(2):1027-9. PubMed ID: 4923064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [R-factor transmission in E. coli: a function of the growth phase of donor cells].
    Bergmann D; Wiedemann B
    Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):303-7. PubMed ID: 4145836
    [No Abstract]   [Full Text] [Related]  

  • 7. Nalidixic acd-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase.
    Helling RB; Kukora JS
    J Bacteriol; 1971 Mar; 105(3):1224-6. PubMed ID: 4926678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the prevention of the development of antibiotic resistance].
    Kozhukhar' IG; Chernomordik AB
    Antibiotiki; 1967 Aug; 12(8):715-7. PubMed ID: 4871879
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfer of drug-resistance (R factor) among strains of Escherichia coli in gnotobiotic pigs.
    Terakado N; Azechi H; Koyama N; Kashiwazaki M; Ninomiya K
    Natl Inst Anim Health Q (Tokyo); 1972; 12(1):23-8. PubMed ID: 4557615
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of Shigella sonnei resistant to kanamycin and to nalidixic acid, without exposure to these drugs.
    Thomas ME; Datta N
    J Med Microbiol; 1969 Nov; 2(4):457-61. PubMed ID: 4929796
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective enrichment of R- segregants as the main mechanism of "curing" of the R factor by acridine dyes.
    Yoshikawa M
    Genet Res; 1971 Feb; 17(1):9-16. PubMed ID: 4933324
    [No Abstract]   [Full Text] [Related]  

  • 13. Frequency of occurrence of E. coli strains capable of transferring multiple resistance in infection of the urinary tract, and properties of some of their R factors.
    Horák V
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(2):264-6. PubMed ID: 4896912
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitivity of Escherichia coli to atabrine conferred by R factor and its potential clinical significance.
    Yoshikawa M; Sevag MG
    J Bacteriol; 1967 Jan; 93(1):245-53. PubMed ID: 5335891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic methods for the study of antibiotic resistance plasmids.
    Davies J
    Methods Enzymol; 1975; 43():41-55. PubMed ID: 1094236
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy and antibiotic-resistance transfer between Enterobacteria in the human gastro-intestinal tract.
    Anderson JD; Gillespie WA; Richmond MH
    J Med Microbiol; 1973 Nov; 6(4):461-73. PubMed ID: 4587394
    [No Abstract]   [Full Text] [Related]  

  • 18. The problems of drug-resistant pathogenic bacteria. In vitro and in vivo methodology for detecting and evaluating inhibitors of transfer of resistance factors.
    Ott JL; Short LJ; Holmes DH
    Ann N Y Acad Sci; 1971 Jun; 182():312-21. PubMed ID: 4936667
    [No Abstract]   [Full Text] [Related]  

  • 19. [Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613].
    Planel'es KhKh; Andreeva AM; Moroz AF
    Antibiotiki; 1968 Jul; 13(7):617-20. PubMed ID: 4880236
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination effects of chemotherapeutic agents. I. Antagonistic effects of 1,10-phenantbroline with nalidixic acid and piromidic acid on the growth of Escherichia coli.
    Yamabe S; Shimizu M
    J Antimicrob Chemother; 1977 Jan; 3(1):101-4. PubMed ID: 321411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.